RT MicroDx transforms diagnostics with innovative, non-invasive, single-use, home-based diagnostic technology that rapidly delivers accurate results, enabling faster treatment and better outcomes.
When Nathalya Mamane experienced firsthand the inefficiencies in our healthcare system, from finding a physician to long wait times for diagnostic testing, she knew there had to be a better way. As both a parent and a patient, Nathalya envisioned more equitable diagnostics that anyone could access, leading her to start RT MicroDx. This vision has become her mission, as she works daily to improve diagnostic accuracy and access through advanced technology and dedicated expertise.
Diagnostics with Highly Sensitive Molecular-Based Technology
Today, RT MicroDx focuses on developing affordable, accurate, home-based molecular diagnostics that offer the accuracy of most lab-based tests without the high cost or inconvenience. Their innovative technology allows for the rapid detection of pathogens and significantly reduces the time needed for diagnostic testing.
A Partnership for Excellence in Healthcare
By providing timely, affordable, convenient diagnostics, RT MicroDx enables timely treatment decisions that can help to improve patient outcomes, resulting in a win-win for patients, providers, and payers. Their technology may be particularly impactful in settings where rapid diagnosis is critical, such as infectious disease outbreaks and emergency care.
RT MicroDx’s commitment to research and development drives them to continually push the boundaries of what is possible in molecular diagnostics. Their dedication to excellence and innovation positions them as a leader in the field, poised to make significant contributions to global health. StarFinder Lab is proud to collaborate with RT MicroDx, a visionary company dedicated to improving access to quality diagnostics and achieving better health outcomes for everyone.